OBLN
Obalon Therapeutics, Inc.
Set alert
52-week range unavailable
- Open
- 3.25
- Prev close
- 3.05
- Mkt cap
- 30.57M
- Vol
- 26.47M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.95
- High
- 4.80
- Forward P/E
- -11.30
- Beta
- -1.24
- Short ratio
- 0.08
- Inst. own
- 31.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2021
- 50-d avg
- 9.14
- 200-d avg
- 9.08
- 1y target
- 6.15
Key statistics
- Market cap
- 30.57M
- Enterprise value
- 22.91M
- Trailing P/E
- 0.00
- Forward P/E
- -11.30
- PEG ratio
- 0.00
- Price / sales
- 37.83
- Price / book
- 3.03
- EPS (TTM)
- -1.38
- Beta
- -1.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 808.00K
- Revenue growth
- 0.00%
- Free cash flow
- -2.73M
- Total cash
- 8.97M
- Total debt
- 1.32M
- Return on equity
- -106.19%
- Shares outstanding
- 10.02M
- Short % of float
- 7.91%
- 50-day average
- 9.14
- 200-day average
- 9.08
Analyst view
Consensus: buy
- Strong buy3
- Buy1
- Hold0
- Sell1
- Strong sell0
Next earnings
Jul 29, 2021
Expected Jul 29, 2021. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 29, 2021 | Jun 1, 2021 | 0.00 | — | — | — |
| May 12, 2021 | Mar 1, 2021 | 0.00 | — | — | — |
| Mar 12, 2021 | Dec 1, 2020 | 0.00 | — | — | — |
| Nov 6, 2020 | Sep 1, 2020 | 0.00 | — | — | — |
| Jul 30, 2020 | Jun 1, 2020 | 0.00 | — | — | — |
| Jun 19, 2020 | Mar 1, 2020 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | Canaccord Genuity | down | Buy | Hold |
| Nov 25, 2020 | Roth Capital | down | Buy | Neutral |
| Nov 25, 2020 | Stifel Nicolaus | up | Hold | Buy |
| Nov 25, 2020 | Stifel Nicolaus | main | Hold | Hold |
| Nov 25, 2020 | Roth Capital | init | — | Buy |
| Nov 25, 2020 | Stifel Nicolaus | main | Hold | Hold |
About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- obalon.com
News
- 54 Biggest Movers From Yesterday
- 77 Biggest Movers From Yesterday
- 62 Biggest Movers From Yesterday
- Stocks That Hit 52-Week Highs On Wednesday
- 71 Biggest Movers From Yesterday
- 52 Stocks Moving In Tuesday's Mid-Day Session
- 40 Stocks Moving in Tuesday's Pre-Market Session
- 78 Biggest Movers From Yesterday
- 54 Stocks Moving In Monday's Mid-Day Session
- Stocks That Hit 52-Week Highs On Monday
Your note
Sign in to keep a note on OBLN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRISTER MARK C | Chief Technology Officer | Stock Award(Grant) | Aug 22, 2018 | 338,634 |
| DITTAMORE RAYMOND V | Director | Stock Award(Grant) | Jul 22, 2019 | 105,597 |
| FISHER DOUGLAS M.D. | Director | Stock Award(Grant) | Jul 22, 2019 | 78,125 |
| HOWE LESLEY H | Director | Stock Award(Grant) | Jul 22, 2019 | 131,459 |
| HUANG KELLY | President | Stock Award(Grant) | Aug 22, 2018 | 119,945 |
| KAMDAR KIM P | Director | Stock Award(Grant) | Jul 22, 2019 | 146,470 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 10.98% | 1,100,000 | 3.10M | Mar 30, 2021 |
| Interwest Venture Management Co. | 3.79% | 380,224 | 1.07M | Mar 30, 2021 |
| Vanguard Group, Inc. (The) | 0.99% | 99,361 | 280.20K | Mar 30, 2021 |
| Renaissance Technologies, LLC | 0.66% | 65,753 | 185.42K | Mar 30, 2021 |
| Geode Capital Management, LLC | 0.57% | 57,161 | 161.19K | Mar 30, 2021 |
| HighPoint Advisor Group LLC | 0.44% | 43,900 | 123.80K | Mar 30, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.99% | 99,361 | 280.20K | Mar 30, 2021 |
| Fidelity Extended Market Index Fund | 0.51% | 51,231 | 144.47K | Mar 30, 2021 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.33% | 33,000 | 93.06K | Mar 30, 2021 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 4,977 | 14.04K | Mar 30, 2021 |
| USAA Mutual Fd Tr-Extended Market Index Fd | 0.01% | 1,449 | 4.09K | Mar 30, 2021 |
| Fidelity Total Market Index Fund | 0.01% | 532 | 1.50K | Mar 30, 2021 |